Memphasys (ASX: MEM) is an Australian-based bio-separations company developing the Felix device – a unique device for quickly separating high quality sperm from a semen sample for use in human IVF procedures. Globally, human fertility rates are in decline and technologies such as IVF are increasing...See more
Headquarters:
Australia
Company Type:
MNC / Large Enterprise
Company size:
11-50 Employees
Employees by Department
- Operations (1)
- Sales (1)
- The Rest (4)
- Total (6)
Key Decision Makers
Financials
LOW
spending power
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- What is the funding status of MEMPHASYS REPRODUCTIVE BIOTECHNOLOGY?
- Where is MEMPHASYS REPRODUCTIVE BIOTECHNOLOGY's headquarter?
- What MEMPHASYS REPRODUCTIVE BIOTECHNOLOGY's spending power?
- Does MEMPHASYS REPRODUCTIVE BIOTECHNOLOGY have a presence in the domain it operates in?
